The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
HIV Preexposure Prophylaxis: A Review
Abstract
IMPORTANCE: About 40 000 Americans and 2 million people worldwide are newly infected with HIV each year. The combination antiretroviral regimen, tenofovir disoproxil fumarate (TDF)/emtricitabine, taken as a single pill once daily, has been shown to prevent HIV transmission but is used by fewer than 20% of people who could benefit in the United States. OBSERVATIONS: PubMed was searched on February 15, 2018, using the search terms pre-exposure, prophylaxis, HIV, and PrEP to identify English-language articles published between 2010 and 2018. Four placebo-controlled randomized clinical trials have demonstrated that preexposure prophylaxis (PrEP) with daily dosing of TDF/emtricitabine significantly reduces HIV acquisition in men who have sex with men, high-risk heterosexuals, and injection drug users who share injection equipment. The efficacy of daily TDF/emtricitabine exceeds 90% but is highly correlated with degree of adherence. TDF/emtricitabine is safe and well-tolerated. Only 2% of people discontinue PrEP because of adverse effects. Sexually transmitted infections are common among those using PrEP. Resistance to TDF/emtricitabine when used for PrEP is rare (<0.1%) and usually occurs when PrEP is inadvertently prescribed to individuals with undiagnosed acute HIV infection who have false-negative findings on HIV antibody/antigen testing due to HIV infection acquired within 7 to 10 days of testing. Effective methods are needed to identify individuals at high risk for acquiring HIV, ensure their access to PrEP, and maximize medication adherence. CONCLUSIONS AND RELEVANCE: TDF/emtricitabine is an effective and safe therapy for preventing HIV transmission. Increasing prescription of TDF/emtricitabine for patients at risk of acquiring HIV has the potential to reduce new HIV infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevention of HIV-1 infection with early antiretroviral therapy.
Cohen, M. S., Chen, Y. Q., McCauley, M., Gamble, T., Hosseinipour, M. C., Kumarasamy, N., Hakim, J. G., Kumwenda, J., Grinsztejn, B., Pilotto, J. H. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105243 · Cited by 6,873
Self-citationPreexposure chemoprophylaxis for HIV prevention in men who have sex with men.
Grant, R. M., Lama, J. R., Anderson, P. L., McMahan, V., Liu, A. Y., Vargas, L., Goicochea, P., Casapía, M., Guanira-Carranza, J. V., Ramirez-Cardich, M. E., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1011205 · Cited by 5,096
Self-citationAntiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
Thigpen, M. C., Kebaabetswe, P. M., Paxton, L. A., Smith, D. K., Rose, C. E., Segolodi, T. M., Henderson, F. L., Pathak, S. R., Soud, F. A., Chillag, K. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1110711 · Cited by 1,996
McCormack, S., Dunn, D. T., Desai, M., Dolling, D. I., Gafos, M., Gilson, R., Sullivan, A. K., Clarke, A., Reeves, I., Schembri, G., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00056-2 · Cited by 1,878
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
Molina, J.-M., Capitant, C., Spire, B., Pialoux, G., Cotte, L., Charreau, I., Tremblay, C., Le Gall, J.-M., Cua, E., Pasquet, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506273 · Cited by 1,633
Preexposure Prophylaxis for HIV Infection among African Women
Van Damme, L., Corneli, A., Ahmed, K., Agot, K., Lombaard, J., Kapiga, S., Malahleha, M., Owino, F., Manongi, R., Onyango, J., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202614 · Cited by 1,603
Choopanya, K., Martin, M., Suntharasamai, P., Sangkum, U., Mock, P. A., Leethochawalit, M., Chiamwongpaet, S., Kitisin, P., Natrujirote, P., Kittimunkong, S., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)61127-7 · Cited by 1,463
Rodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.5148 · Cited by 1,431
Tenofovir-based preexposure prophylaxis for HIV infection among African women.
Marrazzo, J. M., Ramjee, G., Richardson, B. A., Gomez, K., Mgodi, N., Nair, G., Palanee, T., Nakabiito, C., van der Straten, A., Noguchi, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402269 · Cited by 1,296
A case-control study of HIV seroconversion in health care workers after percutaneous exposure.
Cardo, D. M., Culver, D. H., Ciesielski, C. A., Srivastava, P. U., Marcus, R., Abiteboul, D., Heptonstall, J., Ippolito, G., Lot, F., McKibben, P. S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372101 · Cited by 1,198
Anderson, P. L., Glidden, D. V., Liu, A., Buchbinder, S., Lama, J. R., Guanira, J. V., McMahan, V., Bushman, L. R., Casapía, M., Montoya-Herrera, O., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004006 · Cited by 1,020
Self-citationEffectiveness and safety of oral HIV preexposure prophylaxis for all populations
Fonner, V. A., Dalglish, S. L., Kennedy, C. E., Baggaley, R., O’Reilly, K. R., Koechlin, F. M., Rodolph, M., Hodges-Mameletzis, I., & Grant, R. M. (2016) · AIDS · doi:10.1097/qad.0000000000001145 · Cited by 993
Estimating per-act HIV transmission risk: a systematic review
Patel, P., Borkowf, C. B., Brooks, J. T., Lasry, A., Lansky, A., & Mermin, J. (2014) · AIDS · doi:10.1097/qad.0000000000000298 · Cited by 748
Liu, A. Y., Cohen, S. E., Vittinghoff, E., Anderson, P. L., Doblecki-Lewis, S., Bacon, O., Chege, W., Postle, B. S., Matheson, T., Amico, K. R., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.4683 · Cited by 602
Volk, J. E., Marcus, J. L., Phengrasamy, T., Blechinger, D., Nguyen, D. P., Follansbee, S., & Hare, C. B. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ778 · Cited by 489
Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women.
Nel, A., van Niekerk, N., Kapiga, S., Bekker, L.-G., Gama, C., Gill, K., Kamali, A., Kotze, P., Louw, C., Mabude, Z., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602046 · Cited by 479
A CASE-CONTROL STUDY OF HIV SEROCONVERSION IN HEALTH CARE WORKERS AFTER PERCUTANEOUS EXPOSURE
Ardo, M. C., Ulver, D. A. H. C., Iesielski, C. A. A. C., Amela, P., Arcus, R. U. M., Biteboul, D. O. A., Eptonstall, J. U. H., L, F. L., Ibben, P. E. S. M. C. K., & Ell, D. A. M. B. (1997) · Cited by 383
Patterson, K. B., Prince, H. A., Kraft, E., Jenkins, A. J., Shaheen, N. J., Rooney, J. F., Cohen, M. S., & Kashuba, A. D. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3003174 · Cited by 355
Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., Koenig, L. J., & Valleroy, L. A. (2015) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6446a4 · Cited by 352
Herlitz, L. C., Mohan, S., Stokes, M. B., Radhakrishnan, J., D'Agati, V. D., & Markowitz, G. S. (2010) · Kidney International · doi:10.1038/ki.2010.318 · Cited by 348
Marcus, J. L., Hurley, L. B., Hare, C. B., Nguyen, D. P., Phengrasamy, T., Silverberg, M. J., Stoltey, J. E., & Volk, J. E. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001129 · Cited by 286
Anderson, P. L., Liu, A. Y., Castillo-Mancilla, J. R., Gardner, E. M., Seifert, S. M., McHugh, C., Wagner, T., Campbell, K., Morrow, M., Ibrahim, M., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01710-17 · Cited by 272
An HIV Preexposure Prophylaxis Demonstration Project and Safety Study for Young MSM
Hosek, S. G., Rudy, B., Landovitz, R., Kapogiannis, B., Siberry, G., Rutledge, B., Liu, N., Brothers, J., Mulligan, K., Zimet, G., et al. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001179 · Cited by 267
Self-citationVRC 602 Study Team, Ledgerwood, J. E., Coates, E. E., Yamshchikov, G., Saunders, J. G., Holman, L., Enama, M. E., DeZure, A., Lynch, R. M., Gordon, I., et al. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12692 · Cited by 247
Hosek, S. G., Landovitz, R. J., Kapogiannis, B., Siberry, G. K., Rudy, B., Rutledge, B., Liu, N., Harris, D. R., Mulligan, K., Zimet, G., et al. (2017) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2017.2007 · Cited by 220
Self-citationMarkowitz, M., Frank, I., Grant, R. M., Mayer, K. H., Elion, R., Goldstein, D., Fisher, C., Sobieszczyk, M. E., Gallant, J. E., Van Tieu, H., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30068-1 · Cited by 214
Self-citationBaeten, J. M., Heffron, R., Kidoguchi, L., Mugo, N. R., Katabira, E., Bukusi, E. A., Asiimwe, S., Haberer, J. E., Morton, J., Ngure, K., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002099 · Cited by 213
Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV Infection
García-Lerma, J. G., Cong, M.-E., Mitchell, J., Youngpairoj, A. S., Zheng, Q., Masciotra, S., Martin, A., Kuklenyik, Z., Holder, A., Lipscomb, J., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000391 · Cited by 171
Gunawardana, M., Remedios-Chan, M., Miller, C. S., Fanter, R., Yang, F., Marzinke, M. A., Hendrix, C. W., Beliveau, M., Moss, J. A., Smith, T. J., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00656-15 · Cited by 166
Mayer, K. H., Chan, P. A., Patel, R. R., Flash, C. A., & Krakower, D. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001579 · Cited by 151
Self-citationAdams, L. M., & Balderson, B. H. K. (2016) · AIDS Care · doi:10.1080/09540121.2016.1153595 · Cited by 122
Multidrug-Resistant HIV-1 Infection despite Preexposure Prophylaxis
Knox, D. C., Anderson, P. L., Harrigan, P. R., & Tan, D. H. S. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1611639 · Cited by 111
Matthews, L. T., Baeten, J. M., Celum, C., & Bangsberg, D. R. (2010) · AIDS · doi:10.1097/qad.0b013e32833bedeb · Cited by 110
Pre-Exposure Prophylaxis and Antiretroviral Resistance: HIV Prevention at a Cost?
Hurt, C. B., Eron, J., & Cohen, M. S. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir684 · Cited by 102
Krakower, D., Oldenburg, C. E., Mitty, J. A., Wilson, I. B., Kurth, A., Maloney, K. M., Gallagher, D. M., & Mayer, K. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132398 · Cited by 97
Self-citationMarcus, J. L., Volk, J. E., Pinder, J., Liu, A., Bacon, O., Hare, C. B., & Cohen, S. E. (2016) · Current HIV/AIDS Reports · doi:10.1007/s11904-016-0308-x · Cited by 96
Hanscom, B. S., Janes, H., Guarino, P., Huang, Y., Brown, E. R., Chen, Y. Q., Hammer, S. M., Gilbert, P. B., & Donnell, D. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001160 · Cited by 93
Grigsby, I. F., Pham, L., Mansky, L. M., Gopalakrishnan, R., Carlson, A. E., & Mansky, K. C. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.080 · Cited by 90
Kasonde, M., Niska, R. W., Rose, C. E., Henderson, F. L., Segolodi, T. M., Turner, K., Smith, D. K., Thigpen, M. C., & Paxton, L. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090111 · Cited by 84
Hoornenborg, E., Prins, M., Achterbergh, R., Woittiez, L. R., Cornelissen, M. T. E., Jurriaans, S., Kootstra, N. A., Anderson, P. L., Reiss, P., de Vries, H. J. C., et al. (2017) · The Lancet HIV · doi:10.1016/s2352-3018(17)30132-7 · Cited by 81
Markowitz, M. H., Grossman, H. A., Anderson, P. L., Grant, R. M., Gandhi, M., Horng, H., & Mohri, H. (2017) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001534 · Cited by 75
Pre-Exposure Prophylaxis and the Promise of Combination Prevention Approaches
Buchbinder, S., & Liu, A. (2011) · AIDS and Behavior · doi:10.1007/s10461-011-9894-1 · Cited by 63
Murnane, P. M., Heffron, R. A., Ronald, A., Bukusi, E. A., Donnell, D. J., Mugo, N., Were, E. O., Mujugira, A., Kiarie, J. N., Celum, C., et al. (2014) · AIDS · doi:10.1097/qad.0000000000000290 · Cited by 47
Mugwanya, K. K., Baeten, J. M., Celum, C., Donnell, D. J., Nickolas, T. L., Mugo, N., Branch, A. D., Tappero, J. W., Kiarie, J. N., Ronald, A., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw125 · Cited by 46
Solomon, M. M., Schechter, M., Liu, A., McManhan, V. M., Guanira, J. V., Hance, R. J., Chariyalertsak, S., Mayer, K. H., & Grant, R. M. (2015) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000857 · Cited by 45
Self-citationThe current status of the use of oral medication to prevent HIV transmission
Mayer, K. H., & Ramjee, G. (2015) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000170 · Cited by 33
Self-citationMayer, K. H., Maloney, K. M., Levine, K., King, D. S., Grasso, C., Krakower, D., Rosenberg, E. S., & Boswell, S. (2017) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofx214 · Cited by 32
Self-citationMOFENSON, L. M. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1002133 · Cited by 31
Increasing the Clinical Potential and Applications of Anti-HIV Antibodies
Hua, C. K., & Ackerman, M. E. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01655 · Cited by 29
Antiretroviral Preexposure Prophylaxis
Mayer, K. H., Krakower, D., & Boswell, S. (2016) · JAMA · doi:10.1001/jama.2016.0318 · Cited by 3
Self-citation
Metadata
- Authors
- Riddell, J., Amico, K. R., & Mayer, K. H.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2018-03-27
- Volume
- 319
- Issue
- 12
- Pages
- 1261
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2794931281
- Cited by
- 258
- References
- 51
- FWCI
- 24.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.